Citations for
1SMPD3
Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization.
Stoffel W, Hammels I, Jenke B, Schmidt-Soltau I, Niehoff A.
Am J Pathol 189(9):1831-1845. doi: 10.1016/j.ajpath.2019.05.008. Epub 2019 Jun 12. 2019
2SMPD3
Role of SMPD3 during Bone Fracture Healing and Regulation of Its Expression.
Manickam G, Moffatt P, Murshed M.
Mol Cell Biol 39(4). pii: e00370-18. doi: 10.1128/MCB.00370-18. Print 2019 Feb 15. 2019
3SMPD3
SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment.
Stoffel W, Jenke B, Schmidt-Soltau I, Binczek E, Brodesser S, Hammels I.
Cell Death Dis 9(5):507. doi: 10.1038/s41419-018-0560-7. 2018
4SMPD3
Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice.
Zhong L, Kong JN, Dinkins MB, Leanhart S, Zhu Z, Spassieva SD, Qin H, Lin HP, Elsherbini A, Wang R, Jiang X, Nikolova-Karakashian M, Wang G, Bieberich E.
J Lipid Res 59(5):795-804. doi: 10.1194/jlr.M080879. Epub 2018 Mar 22. 2018
5SMPD3
Enriched Expression of Neutral Sphingomyelinase 2 in the Striatum is Essential for Regulation of Lipid Raft Content and Motor Coordination.
Tan LH, Tan AJ, Ng YY, Chua JJ, Chew WS, Muralidharan S, Torta F, Dutta B, Sze SK, Herr DR, Ong WY.
Mol Neurobiol 55(7):5741-5756. doi: 10.1007/s12035-017-0784-z. Epub 2017 Oct 17. 2018
6SMPD3
Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.
Airola MV, Shanbhogue P, Shamseddine AA, Guja KE, Senkal CE, Maini R, Bartke N, Wu BX, Obeid LM, Garcia-Diaz M, Hannun YA.
Proc Natl Acad Sci U S A 114(28):E5549-E5558. doi: 10.1073/pnas.1705134114. Epub 2017 Jun 26. 2017
7SMPD3
Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition.
Stoffel W, Hammels I, Jenke B, Binczek E, Schmidt-Soltau I, Brodesser S, Schauss A, Etich J, Heilig J, Zaucke F.
Cell Death Dis 7(11):e2488. doi: 10.1038/cddis.2016.385. 2016
8SMPD3
Smpd3 Expression in both Chondrocytes and Osteoblasts Is Required for Normal Endochondral Bone Development.
Li J, Manickam G, Ray S, Oh CD, Yasuda H, Moffatt P, Murshed M.
Mol Cell Biol 36(17):2282-99. doi: 10.1128/MCB.01077-15. Print 2016 Sep 1. 2016
9SMPD3
Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation.
Supinski GS, Alimov AP, Wang L, Song XH, Callahan LA.
Am J Physiol Lung Cell Mol Physiol 309(6):L614-24. doi: 10.1152/ajplung.00141.2015. Epub 2015 Jul 2. 2015
10SMPD3
Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
Shamseddine AA, Airola MV, Hannun YA.
Adv Biol Regul 57:24-41. doi: 10.1016/j.jbior.2014.10.002. Epub 2014 Oct 27. Review. 2015
11SMPD3
Neutral sphingomyelinase-2 is a redox sensitive enzyme: role of catalytic cysteine residues in regulation of enzymatic activity through changes in oligomeric state.
Dotson PP 2nd, Karakashian AA, Nikolova-Karakashian MN.
Biochem J 465(3):371-82. doi: 10.1042/BJ20140665. 2015
12SMPD3
Primary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide.
He Q, Wang G, Wakade S, Dasgupta S, Dinkins M, Kong JN, Spassieva SD, Bieberich E.
Mol Biol Cell 25(11):1715-29. doi: 10.1091/mbc.E13-12-0730. Epub 2014 Apr 2. 2014
13SMPD3
Local regulation of tooth mineralization by sphingomyelin phosphodiesterase 3.
Khavandgar Z, Alebrahim S, Eimar H, Tamimi F, McKee MD, Murshed M.
J Dent Res 92(4):358-64. doi: 10.1177/0022034513478429. Epub 2013 Feb 21. 2013
14FOXO1, IL1B, SMPD3
Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism.
Dobierzewska A, Shi L, Karakashian AA, Nikolova-Karakashian MN.
J Biol Chem 287(53):44749-60. doi: 10.1074/jbc.M112.378836. Epub 2012 Oct 26. 2012
15SMPD3
Expression and regulation of enzymes in the ceramide metabolic pathway in human retinal pigment epithelial cells and their relevance to retinal degeneration.
Zhu D, Sreekumar PG, Hinton DR, Kannan R.
Vision Res 50(7):643-51. Epub 2009 Sep 16.PMID: 19765607 2010
16EED, NSMAF, SMPD2, SMPD3, TNFRSF1A
The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase.
Philipp S, Puchert M, Adam-Klages S, Tchikov V, Winoto-Morbach S, Mathieu S, Deerberg A, Kolker L, Marchesini N, Kabelitz D, Hannun YA, Schütze S, Adam D.
Proc Natl Acad Sci U S A 107(3):1112-7. Epub 2009 Dec 28.PMID: 20080539 2010
17SMPD3
Upregulation of smpd3 via BMP2 stimulation and Runx2.
Chae YM, Heo SH, Kim JY, Lee JM, Ryoo HM, Cho JY.
BMB Rep 42(2):86-90.PMID: 19250608 2009
18SMPD2, SMPD3, SMPD4
Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H, Murakami M, Furuhata A, Gao S, Yoshida K, Sobue S, Hagiwara K, Takagi A, Kojima T, Suzuki M, Banno Y, Tanaka K, Tamiya-Koizumi K, Kyogashima M, Nozawa Y, Murate T.
Biochim Biophys Acta 1789(11-12):681-90. Epub 2009 Aug 19.PMID: 19698806 2009
19NSMAF, SMPD3
Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells.
Clarke CJ, Guthrie JM, Hannun YA.
Mol Pharmacol 74(4):1022-32. Epub 2008 Jul 24.PMID: 18653803 2008
20SMPD3
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.
Kim WJ, Okimoto RA, Purton LE, Goodwin M, Haserlat SM, Dayyani F, Sweetser DA, McClatchey AI, Bernard OA, Look AT, Bell DW, Scadden DT, Haber DA.
Blood 111(9):4716-22. Epub 2008 Feb 25.PMID: 18299447 2008
21SMPD3
nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis.
Levy M, Castillo SS, Goldkorn T.
Biochem Biophys Res Commun 344(3):900-5. Epub 2006 Apr 19.PMID: 16631623 2006
22SMPD2, SMPD3
Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N, Luberto C, Hannun YA.
J Biol Chem 278(16):13775-83. Epub 2003 Feb 3.PMID: 12566438 2003
23SMPD3
Cloning and characterization of the mammalian brain-specific, Mg2+-dependentneutral sphingomyelinase.
Hofmann K, Tomiuk S, Wolff G, Stoffel W.
Proc Natl Acad Sci U S A 97(11):5895-900. 2000